NMT Medical Hopes To Avoid Another Headache In Modified Migraine Trial
This article was originally published in The Gray Sheet
Executive Summary
NMT Medical will move forward with its planned PFO closure migraine study under a new trial design cleared recently by FDA, the firm announced Aug. 31
You may also be interested in...
Enrollment Headaches Cause NMT To Drop Migraine Trial
NMT Medical is halting its chase of a migraine indication for its patent foramen ovale closure device after an earlier trial missed its primary endpoint and a second, larger trial has suffered enrollment problems
Enrollment Headaches Cause NMT To Drop Migraine Trial
NMT Medical is halting its chase of a migraine indication for its patent foramen ovale closure device after an earlier trial missed its primary endpoint and a second, larger trial has suffered enrollment problems
Cardica, Cook Join Race To Enter PFO Closure Market
Cardica and Cook Medical are teaming up to develop a patent foramen ovale (PFO) closure device, joining a growing list of firms trying to enter this market. The companies announced the partnership June 19